CANCER

期刊基本信息

期刊名称：CANCER

出版国家或地区：UNITED STATES

是否OA：No

期刊ISSN：0008-543X

期刊官方网站：http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0142

期刊投稿网址：https://mc.manuscriptcentral.com/cancer

通讯方式：JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030

涉及的研究方向：医学-肿瘤学

出版周期：Semimonthly

期刊数据表：

CANCER英文简介：

Cancer, an international interdisciplinary journal of the American Cancer Society, publishes high-impact, peer-reviewed original articles and solicited content on the latest clinical research findings. Each issue of Cancer strives to be comprehensive, spanning the breadth of oncology disciplines and providing something for everyone involved in cancer research, risk reduction, treatment, and patient care.Aims and ScopeCancer seeks to impart highly relevant and timely information to a broad audience of oncology and related specialists in the field. Cancer accomplishes this objective by publishing original and review articles that facilitate the transfer of knowledge from the laboratory to the bedside; contribute to cancer prevention, early detection, diagnosis, cure, and rehabilitation; and diminish suffering from cancer. Cancer also publishes educational supplements on various topics that are of interest to a broad oncology audience..ReadershipOncologists and Oncology Specialists, Hematologists, Radiologists, Basic Science Researchers, Epidemiologists, Pathologists, Cancer Prevention Researchers, Urologists, Gynecologists, Gastroenterologists, Endocrinologists, Pulmonologists, and OtolaryngologistsKeywordsCancer, Diseases, Endocrine disorders, breast cancer, blood diseases, cancer statistics, cancer diagnosis

CANCER中文简介：

《癌症》是美国癌症学会的一份国际跨学科期刊，发表了影响深远、同行评议的原创文章，并就最新的临床研究成果征集内容。癌症的每一个问题都力求全面，跨越肿瘤学学科的广度，为参与癌症研究、风险降低、治疗和患者护理的每个人提供一些东西。目标和范围癌症致力于向广大的肿瘤学和相关领域的专家提供高度相关和及时的信息。癌症通过发表原创和评论文章来实现这一目标，这些文章有助于将知识从实验室转移到临床；为癌症预防、早期发现、诊断、治疗和康复作出贡献;减少癌症带来的痛苦。《癌症》杂志还就广大肿瘤学读者感兴趣的各种主题出版教育补刊。读者肿瘤学家和肿瘤学专家、血液学家、放射科医生、基础科学研究人员、流行病学家、病理学家、癌症预防研究人员、泌尿科医生、妇科医生、胃肠科医生、内分泌科医生、肺科医生和耳鼻喉科医生关键字癌症，疾病，内分泌紊乱，乳腺癌，血液病，癌症统计，癌症诊断

CANCER在线问答：